Vaccination

Push to develop mRNA vaccine patches

The global epidemic innovations fund said Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against COVID.

Oncology & Cancer

Germany's BioNTech plans UK trial of mRNA cancer therapy

German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.

Diseases, Conditions, Syndromes

Researchers make gains in race to protect against RSV

As a surge in cases of respiratory syncytial virus, or RSV, continues pushing hospitals to capacity across the U.S., researchers at Georgia State's Institute for Biomedical Sciences are working to develop vaccines and other ...

Diseases, Conditions, Syndromes

mRNA vaccines offer one-two punch to combat malaria

Malaria is found in more than 90 countries around the world, causing 241 million cases and an estimated 627,000 deaths every year. Vaccines are one intervention that could help eliminate this deadly disease, yet a highly ...

Diseases, Conditions, Syndromes

Experts explain why rates of RSV are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

Medical research

Scientists produce 'DNA virus vaccine' to fight DNA viruses

Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for ...

page 5 from 34